Connect with us

Market News

ZNTL Stock Price News: 6.69% Surge

Published

on

Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL)’s stock price increased by 6.69% as of April 15. The previous closing price was 47.01(14th April) and thus, an increase of 3.27 happened. The closing price of April 15 was 50.28. The day’s range was between  47.26 – 51.69 and the volume was 364,234 (above average).

Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL)’s stock price currently stands at 50.28 and is grossing high if compared to the previous 5 days’ closing prices. 

  • Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) has announced initial efficacy and safety data from the Phase 1 dose-escalation portion of its ongoing Phase 1/2 trial evaluating ZN-c3 in patients with advanced solid tumors who are refractory to or ineligible for standard therapy or for whom no standard therapy is available.

  • Data were presented at the American Association of Cancer Research (AACR) Annual Meeting.

  • Zentalis’ WEE1 inhibitor, ZN-c3, posted partial responses across a slate of tumor types with a tolerable safety profile as monotherapy for solid tumor patients.

  • The drug shrank tumors in two patients: One patient had stage 4 ovarian cancer and had tried 18 lines of treatment, while the other patient had stage 4 colorectal cancer and had undergone five prior lines of treatment.

  • The ovarian cancer patient saw targeted tumors shrink by about 56%. Four weeks into treatment, it saw a “large rapid drop” in blood levels of CA-125, an antigen used to monitor certain cancers.

  • As for the colorectal cancer patient, tumors shrank by 42%, and the patient remained on treatment for about six months before the disease progressed.

  • Three other patients had their tumors shrink, too—including one with Stage IV non-small cell lung cancer (NSCLC) and two with uterine serous carcinoma.

  • The NSCLC patient had received three prior lines of therapy and, after ZN-c3 treatment, achieved an unconfirmed partial response with a 50% reduction in overall target lesions.

  • On the safety front, side effects were mostly mild to moderate, with nausea affecting about half of the 55 patients evaluated for safety, diarrhea, fatigue, and vomiting, afflicting less than one-third of them.

  • Blood-related side effects struck less than 10% of patients: 1.8% of patients suffered a low white blood cell count, 7.2% of patients had a low platelet count, and 7.2% of patients developed anemia.

  • The company initiated the Phase 1 expansion portion of the trial with the 300 mg dose earlier in 2021 and is exploring ZN-c3’s potential in combination trials, including in ovarian cancer and osteosarcoma.

  • Separately, the company has collaborated with GlaxoSmithKline plc (NYSE: GSK) to evaluate the combination of ZN-c3 and Zejula (niraparib) in patients with advanced epithelial ovarian cancer.

  • Under the terms of the non-exclusive collaboration, Zentalis is responsible for conducting the study with GSK supplying niraparib. Zentalis maintains full ownership of ZN-c3.
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Market News

TOP STOCK Market Gainers: LTCN, HL, GCPEF, ABEV, RUN

Published

on

Grayscale Litecoin Trust (OTCMKTS: LTCN)

Grayscale Litecoin Trust’s (OTCMKTS: LTCN) closing price as of May 6 was $445.99. The price hike was recorded to be 17.67%, more than the previous closing price of $379.03. The opening price was $396.00, the volume was 45,765 and the range was 379.05 – 452.12 and respectively. 

Hecla Mining Company (NYSE: HL)

Hecla Mining Company’s (NYSE: HL) closing stock price as of May 6 was $7.29. This showed a growth of 16.64% over the previous closing price of $6.25. The opening price was $6.41, with the volume being 24,884,791 and the day’s range being 6.41 – 7.32. 

GCL-Poly Energy Holdings Limited (OTCMKTS: GCPEF)

GCL-Poly Energy Holdings Limited’s (OTCMKTS: GCPEF) stock price increased by 13.33% over the previous( May 5) closing price of $0.2250. The opening price of May 6 was $0.2400. The volume was 196,480 and the day’s range was 0.2300 – 0.2600.

Ambev S.A. (NYSE: ABEV)

Ambev S.A. (NYSE: ABEV) stock price increased to $3.1200(closing price, May 6) from $2.7900(closing price, May 5). The growth percentage was recorded to be 11.83%. The opening price of May 6 was 3.0600, the volume being 62,369,302 and the range being 2.9800 – 3.1200. 

Sunrun Inc. (NASDAQ: RUN)

Sunrun Inc. (NASDAQ: RUN) stock price increased by 11.69% over the previous closing price( May 5) of $41.84. The closing price of May 6 was sighted to be $46.73. The opening price of May 6-  44.80, volume- 15,073,385 and the range- 43.29 – 46.97.

Continue Reading

Market News

Top 5 Stock Market Gainers: WW, BCRX, HOME, GOLF, SBH

Published

on

WW International, Inc.(NASDAQ: WW)

WW International, Inc.(NASDAQ: WW)’s stock price increased by 25.92% over the previous( May 5) closing price of $27.58 as of May 6. The closing price as of May 6 was $34.73. The opening price was $29.15, the volume was 7,691,487, and the range was between 29.10 – 35.04.

 

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX)

As of May 6, BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX)’s closing price was $12.92. This shows a growth of 20.97% over the previous (May 5) closing price of $10.68. May 6’s opening price, volume, and range were $11.31, 18,023,592, and 10.86 – 13.28 respectively. 

 

At Home Group Inc. (NYSE: HOME)

At Home Group Inc. (NYSE: HOME)’s closing price as of May 6 was $37.70 which is 20.49% more than the previous (May 5) closing price of $31.29.  The opening price of May 6 was $34.59 with the range and volume being 34.56 – 37.75 and 12,459,380 respectively.

 

Acushnet Holdings Corp. (NYSE: GOLF)

Acushnet Holdings Corp. (NYSE: GOLF)’s stock price increased by 20.14% over the previous closing price of $42.91. The opening price (May 6) happened to be $47.79. The day’s range was 46.67 – 51.61 and the volume was  1,145,937. The closing price as of May 6 was 51.55. 

 

Sally Beauty Holdings, Inc. (NYSE: SBH)

As of May 6, the stock price of Sally Beauty Holdings, Inc. (NYSE: SBH) hiked by 20.04% over the previous closing price of $20.29. Thus, the closing price stood at $24.32. The opening price was $23.36, the day’s range was 23.28 – 25.10 and the volume was 7,993,590.

Continue Reading

Market News

Top 5 Stock Gainers Today : LTCN, HAYW, SWRAF, KAR, MED

Published

on

Grayscale Litecoin Trust (OTCMKTS: LTCN)

Grayscale Litecoin Trust (OTCMKTS: LTCN) stock price increased by 26.35% over the previous(May 4) closing price of $299.98. The closing price as of May 5 was $379.03. The day’s range was 300.00 – 419.99. The volume was above average, being 55,484.

Hayward Holdings, Inc. (NYSE: HAYW)

Hayward Holdings, Inc. (NYSE: HAYW) closing price as of May 5 was $24.11 which is $4.72(24.34%) more than the previous(May 4) closing price of $19.39. The opening price was 22.85, the day’s range was 22.32 – 25.28 and the volume was 5,874,811(above average).

Swire Pacific Limited (OTCMKTS: SWRAF)

Swire Pacific Limited (OTCMKTS: SWRAF) stock price increased by 17.73%. The closing price as of May 5 was $8.10 which shows a surge of $1.22 over the previous (May 4) closing price of $6.88. The opening price, as of May 5, was 8.10. The day’s range was 8.10 – 8.10 and the volume was bizarrely above average, 76,195. 

KAR Auction Services, Inc. (NYSE: KAR)

KAR Auction Services, Inc. (NYSE: KAR) stock price surged by a massive amount of 15.99%. The closing price as of May 5 was $16.83 which is $2.32(15.99%) more than the previous( May 4) closing price of $14.51. The opening price was 16.11, the day’s range was 15.80 – 17.48 and the volume was 8,424,928.

Medifast, Inc. (NYSE: MED)

Medifast, Inc. (NYSE: MED)’s closing price as of May 5 was $252.28. The closing price shows a gain of $27.28(12.12%) over the previous closing price of $225.00. The opening price as of April 5 was $232.32, the day’s range was between 248.78 – 264.80 and the volume was 272,741.

Continue Reading

Trending